首页 关于我们 热点透视 政策与规划 产业报道 专利信息 会议报道 联系我们
用户名 密码
 
主题分类
基础研究
干细胞
克隆
基因组学与代谢组学
进化
空间生物学
模式生物与发育生物学
神经科学与脑科学
生物多样性
生殖生物学
营养与健康
生物技术
海洋生物技术
环境生物技术
基因生物技术
空间生物技术
纳米生物技术
农业生物技术
生物信息技术
医药生物技术
生物医学工程
生物安全
食品安全
重大传染病
埃博拉出血热
艾滋病/HIV
非典/SARS
肝炎
高热病
霍乱
流感
轮状病毒
脑膜炎
疟疾
禽流感
血吸虫病
手足口病
重大慢性疾病
癌症
神经退行性疾病
心血管疾病
糖尿病
精神心理疾病
 
重大慢性疾病-癌症-前列腺癌
手术切缘对前列腺癌的死亡率的影响
上传日期:2013-10-11       共有1531人次浏览
 
 
题名: Do Margins Matter? The Influence of Positive Surgical Margins on Prostate Cancer-Specific Mortality.
作者: Andrew J. Stephensona, Scott E. Eggenerb, Adrian V. Hernandez, et al.
单位: Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH, USA
出处: European Urology,2013,():
语种: 英文
文摘:

Background

Positive surgical margins (PSMs) in radical prostatectomy (RP) specimens are a frequent indication for adjuvant radiotherapy and are used as a measure of surgical quality. However, the association between PSMs and prostate cancer–specific mortality (CSM) is poorly defined.

Objective

Analyze the association of PSMs with CSM, adjusting for fixed and time-dependent parameters.

Design, setting, and participants

Fine and Gray competing risk regression analysis was used to model the clinical data and follow-up information of 11 521 patients treated by RP between 1987 and 2005. Two extended models were used that adjusted for the use of postoperative radiotherapy, which was handled as a time-dependent covariate. Postoperative radiotherapy was modeled as a single parameter and also as early and late therapy, based on the prostate-specific antigen level at the start of treatment (≤0.5 vs >0.5 ng/ml).

Intervention

RP for clinically localized prostate cancer and selective use of secondary local and/or systemic therapy.

Outcome measurements and statistical analysis

The outcome measure was prostate cancer-specific mortality.

Results and limitations

The 15-yr CSM rates for patients with PSMs and negative surgical margins were 10% and 6%, respectively (p < 0.001). No significant association between PSM and CSM was observed in the conventional model with fixed covariates (hazard ratio [HR]: 1.04; 95% confidence interval [CI], 0.7–1.5; p = 0.8) or in the two extended models that adjusted for postoperative radiotherapy (HR: 0.96; 95% CI, 0.7–1.4; p = 0.9), or early and late postoperative radiotherapy (HR: 1.01; 95% CI, 0.7–1.4; p = 0.9).

Conclusions

PSMs alone are not associated with a significantly increased risk of CSM within 15 yr of RP. However, urologists should continue to strive to avoid PSMs, as they increase a man's risk of biochemical recurrence and need for secondary therapy and may be a source of considerable patient anxiety.

http://dx.doi.org/10.1016/j.eururo.2013.08.036

关键词: Prostatic neoplasms; Prostatectomy; Surgical margins; Treatment outcome; Models; Statistical

<< 返回上一页

联系地址:上海市岳阳路319号31号楼A座 邮政编码:200031
联系电话:021-54922971;02154922966 Email: lsdb@sibs.ac.cn
主办单位:中国科学院 生命科学与生物技术局 生物医学处
版权所有:中国科学院上海生命科学信息中心        沪ICP备05033115号